Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-01-01 @ 5:28 AM
Study NCT ID:
NCT02148133
Status:
COMPLETED
Last Update Posted:
2019-05-03
First Post:
2014-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-22
First Submit QC Date:
None
Study First Post Date:
2014-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-27
Results First Submit QC Date:
None
Results First Post Date:
2019-05-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-31
Last Update Post Date:
2019-05-03
Last Update Post Date Type:
ACTUAL